Skip to main content
Fig. 2 | Lipids in Health and Disease

Fig. 2

From: Ergothioneine ameliorates metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) by enhancing autophagy, inhibiting oxidative damage and inflammation

Fig. 2

Ergothioneine ameliorated hepatic structural damage, hyperlipidemia, oxidative damage, and inflammation in HFD mice. (A) HE, PAS, Oil Red, and IHC (F4/80) staining. Bar = 100 μm. Serum levels of TG (B), TC (C), LDL-C (D) and HDL-C (E) in mice. ELISA kits detected serum levels of SOD (F), CAT (G), GSH (H), MDA (I), IL-1β (J) and IL-6 (K) in mice. n = 5. ** P < 0.01, *** P < 0.001, **** P < 0.0001 HFD vs. NCD; #P < 0.05, ##P < 0.01, ###P < 0.001, ####P < 0.0001 HFD + EGT vs. HFD

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X